在这些情况下,我用脏剥离来治疗高血压
Claudio Borghi1, Alessio Bragagni1
1Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
概括
脏缩 (RDN) 通过调节交感神经系统,为耐性高血压提供了一种新的微创治疗方法. 这种方法可能有利于难以治疗的患者,在与多学科护理相结合时降低心血管风险.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 系统性动脉高血压是全球主要的健康问题,许多患者对标准治疗没有反应.
- 脏缩 (RDN) 针对脏交感神经系统,提供了一种新的治疗策略.
- 临床试验的可变结果需要精细的患者选择和理解RDN的作用.
研究的目的:
- 审查当前的证据和指导方针,用于治疗全身性动脉高血压的性化.
- 突出 RDN 的潜力,作为一种抗性高血压的突破性疗法.
- 强调患者选择和多学科评估对于优化 RDN 结果的重要性.
主要方法:
- 最近临床试验的审查 (简单性HTN-3,螺旋HTN-OFF MED,辐射HTN单独).
- 分析2024年欧洲心脏病学会 (ESC) 关于RDN的指导方针.
- 讨论 RDN 技术 (超声波,射频) 和它们的应用.
主要成果:
- 对RDN的临床试验结果是可变的,受患者选择和研究设计的影响.
- 2024年欧洲经济委员会指导方针支持RDN用于某些抗性高血压病例.
- 个体患者的病理生理学和交感激活水平会影响RDN反应.
结论:
- 脏缩代表了耐药高血压患者药物控制不充分的有前途的治疗选择.
- 超声波和射频RDN技术可以弥合治疗差距并降低长期心血管风险.
- 多学科的方法对于最大限度地发挥损伤的好处至关重要.
更多相关视频
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.5K
08:21A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
4.6K
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
440
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
440
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
376
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
376
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
530
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
530
01:16Antihypertensive Drugs: Action of Diuretics
572
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
572
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
401
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
401